Balyasny Asset Management
ARDT

Balyasny Asset Management’s Ardent Health ARDT Stock Holding History

Balyasny Asset Management’s Portfolio ARDT Stock Details ARDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$230K Sell
23,424
-20,451
-47% -$194K ﹤0.01% 2781
2026
Q1 		$376K Buy
43,875
+2,037
+5% +$18.3K ﹤0.01% 2477
2025
Q4 		$369K Buy
+41,838
New +$484K ﹤0.01% 2653
2025
Q2 		– Sell
-28,756
Closed -$395K – 3470
2025
Q1 		$395K Buy
28,756
+12,782
+80% +$187K ﹤0.01% 2352
2024
Q4 		$273K Buy
+15,974
New +$277K ﹤0.01% 2432

Other funds holding ARDT

CTC
Chai Trust Company Chicago, Illinois $1.45B AUM 10.17% 1-Year Est. Return
VI
Ventas Inc Chicago, Illinois $91.9M AUM 27.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
CM
CastleKnight Management New York $7.38B AUM 133.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Balyasny Asset Management's ARDT Position: Q2 2026 in Review

Balyasny Asset Management reduced its Ardent Health (ARDT) stake by 47% in Q2 2026, selling an estimated $194K and leaving 23,424 shares worth $230K. The position accounts for ﹤0.01% of the portfolio, ranked #2781.

Balyasny Asset Management first reported a position in ARDT in Q4 2024 and has held it in 5 quarters since. The position peaked at $395K in Q1 2025. 139 funds tracked by Wall St. Rank hold ARDT as of Q2 2026.

  • Balyasny Asset Management held 23,424 shares of Ardent Health worth $230K as of Q2 2026.
  • Balyasny Asset Management sold 20,451 Ardent Health shares in Q2 2026, an estimated $194K.
  • Ardent Health made up ﹤0.01% of Balyasny Asset Management's portfolio in Q2 2026, its #2781 holding.
  • Balyasny Asset Management first reported a position in Ardent Health in Q4 2024 and has held it in 5 quarters since.
  • Balyasny Asset Management's Ardent Health position peaked at $395K in Q1 2025.
  • 139 funds tracked by Wall St. Rank held Ardent Health as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.